Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

2:56 PM ET 8-K
Capital Raise Principal Credit Real Estate Income Trust

Principal Credit Real Estate Income Trust Capital Raise of $650K

Principal Credit Real Estate Income Trust sold 31,925.51 common shares for approximately $650,000 in a continuous private offering. The sale included Class F-S and Class F-I common shares to third-party investors under a Regulation D exemption.

Value
$650K
12:52 PM ET 8-K
M&A Deal JLL Income Property Trust, Inc. ZIPTAX

JLL Income Property Trust Signs $36M M&A Deal with West Boston Distribution Center

JLL Income Property Trust acquired the West Boston Distribution Center, a 54,000-square-foot Class A industrial facility in Northborough, MA, for approximately $36 million. The property is 100% leased to a leading distribution tenant with 14 years remaining on the lease and 2.5% annual rent escalations.

Value
$36M
Counterparty
West Boston Distribution Center
12:52 PM ET 8-K
M&A Deal Helen of Troy Ltd HELE

Helen of Troy M&A Deal with Empower Brands Holdings Group, LLC

Helen of Troy's Board of Directors unanimously rejected an unsolicited, non-binding proposal from Empower Brands (owned by Spectrum Brands and Oaktree Capital) to acquire the company for $37.00 per share in cash. The Board determined the offer substantially undervalues the company's long-term strategic roadmap and current performance momentum. The company also released an investor presentation detailing its three-phase value creation plan and rationale for remaining independent.

Counterparty
Empower Brands Holdings Group, LLC
12:48 PM ET 8-K
Capital Raise Cottonwood Communities, Inc.

Cottonwood Communities Capital Raise of $2.83M

Cottonwood Communities, Inc. issued and sold 284,186 shares of its Series A Convertible Preferred Stock in a private placement offering between October 27 and November 3, 2026. The company received aggregate proceeds of approximately $2.83 million at a purchase price of $10.00 per share. This sale is part of an ongoing private offering of up to $200 million in preferred stock to accredited investors.

Value
$2.83M
12:02 PM ET 8-K/A
Capital Raise Macquarie Infrastructure Fund, L.P.

Macquarie Infrastructure Fund Capital Raise of $950K

Macquarie Infrastructure Fund, L.P. sold unregistered Class I limited partnership units for aggregate consideration of approximately $0.95 million on October 1, 2026. The sale was part of a continuous private offering to accredited investors and qualified purchasers, with the broader MIF Program raising approximately $131.0 million during the same period.

Value
$950K
11:59 AM ET
Earnings Call Riot Platforms, Inc. RIOT ▶ Call

Riot Platforms Earnings Call: Key Takeaways

Riot Platforms is pivoting from Bitcoin mining to AI infrastructure, securing $38 billion in contracted revenue through massive long-term leases with AMD and frontier AI labs.

Call
Nov 4, 2026, 8:00 AM ET
10:41 AM ET 8-K
M&A Deal Array Technologies, Inc. ARRY

Array Technologies M&A Deal with Shoals Technologies Group, Inc.

Array Technologies entered into a definitive agreement to acquire Shoals Technologies Group in an all-stock merger, creating an integrated solar energy infrastructure platform. Shoals shareholders will receive 1.6931 shares of Array common stock for each Shoals share, resulting in Shoals shareholders owning approximately 65% of the combined company. The transaction is expected to generate over $100 million in annual Adjusted EBITDA synergies within three years.

Counterparty
Shoals Technologies Group, Inc.
9:37 AM ET 8-K
Clinical Trial Data Oncolytics Biotech Inc ONCY

Oncolytics Biotech Clinical Trial Data

Oncolytics Biotech announced translational data from an ongoing Phase 1/2 study of pelareorep in combination with a checkpoint inhibitor for squamous cell anal cancer (SCAC). The data showed that the treatment more than doubled immune activation levels in nearly all patients and expanded HPV-16-specific T cell clones, which was associated with tumor shrinkage and objective responses.

9:26 AM ET 8-K
M&A Deal Shoals Technologies Group, Inc. SHLS

Shoals Technologies Group M&A Deal with Array Technologies, Inc.

Shoals Technologies Group entered into a definitive merger agreement to be acquired by Array Technologies in an all-stock transaction. Shoals shareholders will receive 1.6931 shares of Array common stock for each Shoals share, resulting in Shoals shareholders owning approximately 65% of the combined energy infrastructure company.

Counterparty
Array Technologies, Inc.
9:18 AM ET 8-K
Clinical Trial Data Cullinan Therapeutics, Inc. CGEM

Cullinan Therapeutics Clinical Trial Data

Cullinan Therapeutics released updated Phase 1 dose escalation data for CLN-049 in patients with relapsed or refractory AML and MDS, showing an ORR of 45% at the 12 µg/kg dose level. The company also announced that these results, along with data for velinotamig, will be presented at the 68th ASH Annual Meeting in December 2026. The data demonstrated that a two step-up dosing regimen improved safety by reducing the incidence and severity of cytokine release syndrome.

9:10 AM ET 8-K
Divestiture Penguin Solutions, Inc. PENG

Penguin Solutions Divestiture to Transom Capital Group, LLC

Penguin Solutions has entered into a definitive agreement to sell its Cree LED business (Optimized LED segment) to Transom Capital Group in an all-cash transaction. The divestiture is part of the company's strategy to transform into a pure-play data center AI infrastructure solutions provider. The deal is expected to close in the first calendar quarter of 2027, subject to customary closing conditions.

Counterparty
Transom Capital Group, LLC
9:08 AM ET 8-K
M&A Deal Luxfer Holdings PLC LXFR

Luxfer Holdings Signs $469M M&A Deal with Double Eagle Acquisition Buyer, Inc.

Luxfer Holdings PLC shareholders have voted to approve the company's acquisition by Double Eagle Acquisition Buyer, Inc., an affiliate of Wynnchurch Capital, L.P. Under the terms of the agreement, shareholders will receive $17.37 per share in cash, valuing the equity at approximately $468.9 million. The transaction is expected to close by the end of November 2026, at which point Luxfer will become a privately held company.

Value
$469M
Counterparty
Double Eagle Acquisition Buyer, Inc.
9:07 AM ET 8-K
Capital Raise Lyell Immunopharma, Inc. LYEL

Lyell Immunopharma Capital Raise of $80M

Lyell Immunopharma entered into a securities purchase agreement to raise $80.0 million through a private placement of 7,428,040 shares of common stock. The shares were sold to institutional accredited investors at a price of $10.77 per share, with the company agreeing to file a resale registration statement within 30 days of closing.

Value
$80M
Counterparty
institutional accredited investors
9:00 AM ET 8-K
Capital Raise HarbourVest Private Equity Secondaries Fund L.P.

HarbourVest Private Equity Secondaries Fund Capital Raise of $1.95M

HarbourVest Private Equity Secondaries Fund L.P. sold 159,793 Class I Units for aggregate consideration of approximately $1.9 million on October 1, 2026. The sale was part of a continuous private offering to accredited investors and qualified purchasers, with the unit price finalized at a Transactional NAV of $12.17 per unit.

Value
$1.95M
8:41 AM ET 8-K
Capital Raise reAlpha Tech Corp. AIRE

reAlpha Tech Capital Raise of $1.75M

reAlpha Tech Corp. announced the pricing of a $1.75 million best efforts public offering of 4,375,000 shares of common stock (including pre-funded warrants) at $0.40 per share. The company intends to use the net proceeds for working capital, general corporate purposes, and potential acquisitions or litigation settlements.

Value
$1.75M
8:17 AM ET 8-K
Capacity Expansion Terawulf Inc. WULF

Terawulf Capacity Expansion: $19B Investment

TeraWulf executed a definitive EPC agreement with Fluor for the construction of three data center buildings at its Justified Data Campus in Kentucky, supporting a $19 billion lease with Anthropic. Additionally, Google LLC entered into credit support agreements to backstop Anthropic's lease obligations, significantly strengthening the project's financing profile.

Value
$19B
Counterparty
Anthropic, PBC
Term
20 years
7:47 AM ET 8-K
M&A Deal Eagle Nuclear Energy Corp. NUCL

Eagle Nuclear Energy M&A Deal with Noble Plains Uranium Corp.

Eagle Nuclear Energy Corp. has signed a binding letter of intent to acquire 100% of Noble Plains Uranium Corp. in an all-stock transaction. The deal values Noble Plains at CAD $0.125 per share, a 92% premium, and will expand Eagle's domestic uranium portfolio into Wyoming's Powder River and Shirley basins.

Counterparty
Noble Plains Uranium Corp.
7:41 AM ET 8-K
M&A Deal Spectrum Brands Holdings, Inc. SPB

Spectrum Brands Holdings Signs $1.6B M&A Deal with Helen of Troy Limited

Spectrum Brands' joint venture, Empower Brands, has submitted a non-binding proposal to acquire all outstanding shares of Helen of Troy Limited for $37.00 per share in cash. The deal implies an enterprise value of approximately $1.6 billion and represents a 31% premium over the target's 30-day volume-weighted average share price. Empower Brands, which is jointly owned by Spectrum Brands and Oaktree Capital Management, already holds a 4.5% stake in Helen of Troy.

Value
$1.6B
Counterparty
Helen of Troy Limited
7:08 AM ET 8-K
M&A Deal Worksport Ltd WKSP

Worksport M&A Deal Update

Worksport Ltd. has signed a term sheet for its first-ever acquisition, targeting a patented, U.S.-manufactured truck bed accessory business and its IP portfolio. The company plans to leverage its existing West Seneca manufacturing facility and distribution network to cross-sell and bundle the new product with its tonneau covers.

7:02 AM ET 8-K
Clinical Trial Data Genprex, Inc. GNPX

Genprex Clinical Trial Data

Genprex announced new research identifying TROP2 expression as a potential predictive biomarker for response to its lead gene therapy candidate, Reqorsa, in non-small cell lung cancer (NSCLC). Data from preclinical models and patient biopsies showed that low TROP2 expression is associated with resistance to treatment, which could help the company select more applicable patients for future clinical trials.

7:02 AM ET 8-K
Product Launch D-Wave Quantum Inc. QBTS

D-Wave Quantum Product Launch

D-Wave Quantum announced performance enhancements to its Stride hybrid solver and launched a new three-course Applied Quantum Optimization learning path. The updated solver, available via the Leap quantum cloud service, demonstrated significant speed and quality improvements in benchmark testing for complex optimization problems like the traveling salesperson problem.

6:44 AM ET 8-K
M&A Deal GP-Act III Acquisition Corp. GPAT

GP-Act III Acquisition Signs $500M M&A Deal with Dronamics Group Limited

GP-Act III Acquisition Corp. (GPAT) has entered into a definitive business combination agreement with Dronamics Group Limited, a developer of long-range unmanned aircraft systems, at an implied pro-forma enterprise value of $500 million. The transaction is expected to provide approximately $100 million in net cash proceeds to Dronamics to scale production of its Black Swan aircraft and accelerate commercial operations. Upon closing, expected in the first half of 2027, the combined company will list on Nasdaq.

Value
$500M
Counterparty
Dronamics Group Limited
6:34 AM ET 8-K
Divestiture CVS Health Corp CVS

CVS Health Divestiture

CVS Health announced its intention to separate into two independent, publicly traded companies: a healthcare solutions company (including Aetna and Caremark) and a national retail pharmacy company (CVS Pharmacy). The transaction is expected to be completed in the first half of 2028 and is intended to be tax-free for the company and its shareholders.

6:10 AM ET 8-K
M&A Deal Addentax Group Corp. ATXG

Addentax Group M&A Deal with Chan Kai Sang

Addentax Group Corp., through its subsidiary Yingxi Industrial Chain Investment Co., Ltd, has entered into a definitive agreement to acquire 100% of Double Cash Finance Limited from its sole shareholder, Chan Kai Sang. As consideration for the acquisition, the company will issue 464,907 shares of its common stock to the seller. The transaction is subject to customary closing conditions, including the filing of a Nasdaq Listing of Additional Shares Notification.

Counterparty
Chan Kai Sang
6:04 AM ET 8-K
M&A Deal Bioadaptives, Inc. BDPT

Bioadaptives M&A Deal with Xycota Biosciences LLC

BioAdaptives, Inc. entered into a definitive agreement to acquire 100% of Xycota Biosciences LLC, a preclinical biotechnology company focused on CNS product candidates. As consideration, BioAdaptives will issue a new series of convertible preferred stock to Xycota's founders representing 40% of the company's total voting and economic power. Following the transaction, Xycota will operate as a separate subsidiary under its existing leadership while maintaining ring-fenced operational and financial structures.

Counterparty
Xycota Biosciences LLC
6:04 AM ET 8-K
M&A Deal Lake Superior Acquisition Corp LKSP

Lake Superior Acquisition Signs $300M M&A Deal with Openmarkets Group Pty Ltd

Lake Superior Acquisition Corp. entered into an Amended and Restated Business Combination Agreement with Openmarkets Group Pty Ltd (OMG) for a deal valued at $300 million. The revised structure involves a simultaneous merger and share exchange where OMG shareholders will receive Pubco ordinary shares at a deemed value of $10.00 per share. The amendment updates the pre-closing ownership structure and transaction sequencing to facilitate the business combination.

Value
$300M
Counterparty
Openmarkets Group Pty Ltd
6:24 PM ET
Earnings Call Advanced Micro Devices Inc AMD ▶ Call

Advanced Micro Devices Earnings Call: Key Takeaways

AMD delivered record Q3 results driven by massive data center growth and raised 2027 revenue guidance to over 80% growth.

Call
Nov 3, 2026, 5:00 PM ET
5:16 PM ET 8-K
M&A Deal Finward Bancorp FNWD

Finward Bancorp M&A Deal with First Financial Bancorp.

Finward Bancorp shareholders approved the previously announced merger agreement with First Financial Bancorp. at a special meeting held on November 2, 2026. Approximately 70.3% of outstanding shares were represented, with the merger proposal receiving overwhelming support from voting shareholders.

Counterparty
First Financial Bancorp.
5:07 PM ET 8-K
M&A Deal Titan Acquisition Corp. TACH

Titan Acquisition M&A Deal with OpenPayd Holdings Limited

Titan Acquisition Corp, a SPAC, filed an updated investor presentation regarding its pending business combination with OpenPayd Holdings Limited. The presentation provides strategic and financial details for use in meetings with existing and potential shareholders as the parties work toward closing the merger.

Counterparty
OpenPayd Holdings Limited
5:01 PM ET 8-K
Capital Raise SPACCircle Acquisition Corp. SCQC

SPACCircle Acquisition Capital Raise of $103M

SPACCircle Acquisition Corp. consummated its initial public offering of 10,000,000 units at $10.00 per unit, generating $100 million in gross proceeds. Simultaneously, the company completed a private placement of 266,590 units to its sponsor, SPACCircle Sponsor LLC, for approximately $2.67 million. A total of $100.5 million was placed in a trust account to fund a future business combination.

Value
$103M
Counterparty
SPACCircle Sponsor LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.